| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T16921 |
3-7 |
PR:000015682 |
denotes |
ogra |
| T269 |
56-64 |
SP_7 |
denotes |
COVID-19 |
| T29040 |
131-137 |
CHEBI:30563;CHEBI:30563 |
denotes |
iterat |
| T66582 |
138-143 |
CHEBI:41865;CHEBI:41865 |
denotes |
re on |
| T270 |
172-180 |
SP_7 |
denotes |
COVID-19 |
| T45946 |
204-215 |
GO:0009986 |
denotes |
2020). Redu |
| T271 |
225-235 |
CL:0000542 |
denotes |
lymphocyte |
| T29057 |
253-266 |
CHEBI:17089;CHEBI:17089;BV_11 |
denotes |
.0001) (Table |
| T48572 |
271-281 |
CHEBI:33563;CHEBI:33563 |
denotes |
particula |
| T81590 |
289-302 |
CHEBI:5386;CHEBI:5386 |
denotes |
he numbers of |
| T272 |
303-316 |
CL:0000084 |
denotes |
T lymphocytes |
| T273 |
321-324 |
PR:000001004 |
denotes |
CD4 |
| T274 |
326-339 |
CL:0000084 |
denotes |
T lymphocytes |
| T13440 |
390-397 |
NCBITaxon:10239 |
denotes |
ase sev |
| T275 |
481-489 |
SP_7 |
denotes |
COVID-19 |
| T86499 |
496-501 |
NCBITaxon:10239 |
denotes |
in Wu |
| T276 |
550-553 |
PR:000001004 |
denotes |
CD4 |
| T277 |
555-561 |
CL:0000084 |
denotes |
T cell |
| T278 |
583-595 |
GO:0065007 |
denotes |
dysregulated |
| T279 |
596-602 |
UBERON:0002405;GO:0006955 |
denotes |
immune |
| T280 |
603-611 |
GO:0006955 |
denotes |
response |
| T73491 |
603-612 |
CHEBI:59132;CHEBI:59132 |
denotes |
response |
| T281 |
645-653 |
SP_7 |
denotes |
COVID-19 |
| T282 |
727-745 |
PR:000005897 |
denotes |
C-reactive protein |
| T19907 |
733-744 |
CHEBI:26667;CHEBI:26667 |
denotes |
tive protei |
| T283 |
747-750 |
PR:000005897 |
denotes |
CRP |
| T284 |
766-779 |
PR:000001393 |
denotes |
interleukin-6 |
| T285 |
781-785 |
PR:000001393 |
denotes |
IL-6 |
| T286 |
801-812 |
CL:0000232 |
denotes |
erythrocyte |
| T44302 |
803-808 |
CHEBI:18059;CHEBI:18059 |
denotes |
ythro |
| T19708 |
841-848 |
NCBITaxon:10239 |
denotes |
= 0.000 |
| T287 |
852-857 |
UBERON:0001977 |
denotes |
serum |
| T34653 |
988-1008 |
GO:0005771 |
denotes |
S1B; Table S1). We u |
| T12143 |
1016-1030 |
GO:0005770 |
denotes |
a combination |
| T30110 |
1038-1052 |
GO:0005576 |
denotes |
ted lipidomics |
| T56466 |
1064-1073 |
NCBITaxon:9606 |
denotes |
2019) an |
| T27888 |
1074-1075 |
NCBITaxon:10376 |
denotes |
|
| T73703 |
1076-1081 |
NCBITaxon:10239 |
denotes |
ntarg |
| T44893 |
1083-1086 |
NCBITaxon:11886 |
denotes |
ed |
| T89144 |
1094-1099 |
SP_6;NCBITaxon:9606 |
denotes |
mics |
| T6479 |
1116-1121 |
NCBITaxon:10239 |
denotes |
e for |
| T288 |
1132-1137 |
SP_6;NCBITaxon:9606 |
denotes |
human |
| T289 |
1138-1144 |
UBERON:0001969 |
denotes |
plasma |
| T290 |
1216-1226 |
CHEBI:25212;CHEBI:25212 |
denotes |
metabolite |
| T77915 |
1221-1236 |
GO:0005886 |
denotes |
olite peaks wit |
| T44878 |
1255-1260 |
NCBITaxon:10239 |
denotes |
ariat |
| T26221 |
1317-1330 |
GO:0005622 |
denotes |
n of backgrou |
| T57680 |
1378-1387 |
GO:0005764;GO:0043161 |
denotes |
ation bas |
| T33503 |
1388-1399 |
GO:0009056 |
denotes |
d on tandem |
| T93076 |
1409-1424 |
GO:0005886 |
denotes |
trometry (MS/MS |
| T291 |
1452-1458 |
UBERON:0001969 |
denotes |
plasma |
| T292 |
1459-1469 |
CHEBI:25212;CHEBI:25212 |
denotes |
metabolome |
| T16180 |
1468-1471 |
PR:000001004 |
denotes |
e f |
| T43623 |
1473-1480 |
CL:0000084 |
denotes |
ally co |
| T58503 |
1485-1494 |
GO:0007416 |
denotes |
ed 1,002 |
| T293 |
1494-1505 |
CHEBI:25212;CHEBI:25212 |
denotes |
metabolites |
| T294 |
1511-1517 |
CHEBI:18059;CHEBI:18059 |
denotes |
lipids |
| T56792 |
1511-1519 |
GO:0045202;GO:0007129 |
denotes |
lipids a |
| T295 |
1532-1543 |
CHEBI:25212;CHEBI:25212 |
denotes |
metabolites |
| T38933 |
1565-1578 |
NCBITaxon:11118 |
denotes |
internal sta |
| T304 |
1639-1647 |
SP_7 |
denotes |
COVID-19 |
| T82510 |
1648-1675 |
GO:0005793 |
denotes |
Patients
Total (n = 50) Mil |
| T86084 |
1702-1707 |
GO:0005793 |
denotes |
) Sev |
| T55962 |
1721-1726 |
NCBITaxon:10239 |
denotes |
Valu |
| T306 |
1751-1752 |
UBERON:0000341 |
denotes |
a |
| T308 |
1772-1776 |
UBERON:0001443 |
denotes |
32.0 |
| T61412 |
1783-1801 |
GO:0030133 |
denotes |
40.0) 45.0 (38.0–5 |
| T46161 |
1802-1809 |
GO:0006900 |
denotes |
.5) 50. |
| T89037 |
1819-1830 |
GO:0005802 |
denotes |
.0) 0.001
O |
| T53346 |
1880-1891 |
NCBITaxon:11118 |
denotes |
.0–8.0) 4.0 |
| T96946 |
1892-1897 |
NCBITaxon:39107 |
denotes |
(2.0– |
| T8299 |
1898-1907 |
NCBITaxon:5690 |
denotes |
.0) 6.0 ( |
| T89305 |
1908-1913 |
NCBITaxon:10239 |
denotes |
.0–7. |
| T73232 |
1926-1929 |
NCBITaxon:11757 |
denotes |
0.0 |
| T66261 |
1977-1981 |
GO:0009986 |
denotes |
11.0 |
| T18482 |
1982-1990 |
GO:0034399 |
denotes |
27.0) 8. |
| T12427 |
2035-2045 |
UBERON:0001004 |
denotes |
) 0.02
Sex |
| T16384 |
2057-2061 |
SP_9;NCBITaxon:8088 |
denotes |
30 ( |
| T77789 |
2063-2068 |
NCBITaxon:10239 |
denotes |
%) 9 |
| T21588 |
2097-2116 |
SO:0001528 |
denotes |
20 (40%) 9 (50%) 7 |
| T96353 |
2135-2141 |
SO:0000417 |
denotes |
sure t |
| T54812 |
2149-2158 |
PG_3 |
denotes |
26 (52%) |
| T38186 |
2199-2211 |
CHEBI:5386;CHEBI:5386 |
denotes |
idity 18 (36 |
| T75580 |
2215-2222 |
NCBITaxon:40674 |
denotes |
(17%) |
| T26192 |
2261-2276 |
CHEBI:35381;CHEBI:35381 |
denotes |
16%) 0 3 (16%) |
| T39043 |
2281-2293 |
CHEBI:26667;CHEBI:26667 |
denotes |
%) 0.016
Di |
| T87021 |
2317-2326 |
GO:0016020 |
denotes |
(11%) 2 ( |
| T71738 |
2416-2431 |
GO:0005794 |
denotes |
disease 2 (4%) |
| T90749 |
2436-2450 |
GO:0005770 |
denotes |
2 (15%) 0.052 |
| T38833 |
2567-2582 |
GO:0005770 |
denotes |
,°C 0.702
<37. |
| T49954 |
2664-2675 |
GO:0042592 |
denotes |
–39.0 22 (4 |
| T40565 |
2679-2683 |
CHEBI:62964;CHEBI:62964 |
denotes |
6 (3 |
| T27770 |
2683-2698 |
CHEBI:74537;CHEBI:74537 |
denotes |
3%) 10 (53%) 6 |
| T27576 |
2698-2699 |
CHEBI:62964;CHEBI:62964 |
denotes |
( |
| T21964 |
2699-2709 |
CHEBI:18367;CHEBI:18367 |
denotes |
46%)
>39. |
| T84487 |
2711-2714 |
PR:000000034 |
denotes |
8 ( |
| T63557 |
2726-2730 |
CHEBI:18059;CHEBI:18059 |
denotes |
3 ( |
| T47530 |
2776-2779 |
PR:000012622 |
denotes |
1 ( |
| T64446 |
2805-2819 |
GO:0005770 |
denotes |
5 (30%) 3 (17% |
| T92266 |
2859-2866 |
NCBITaxon:10239 |
denotes |
%) 1 (6 |
| T51172 |
2905-2909 |
CHEBI:18059;CHEBI:18059 |
denotes |
) 5 |
| T63873 |
2910-2919 |
GO:0016020 |
denotes |
28%) 7 (3 |
| T14809 |
2988-3000 |
UBERON:0002405 |
denotes |
(17%) 2 (11% |
| T49903 |
3044-3048 |
GO:0018995 |
denotes |
0 1 |
| T95193 |
3049-3061 |
GO:0065007 |
denotes |
5%) 5 (38%) |
| T24997 |
3093-3098 |
NCBITaxon:10239 |
denotes |
%) 0. |
| T11315 |
3099-3110 |
GO:0006260 |
denotes |
34
Diarrhea |
| T86600 |
3496-3504 |
SP_7 |
denotes |
OVA (ons |
| T63986 |
3539-3549 |
SP_7 |
denotes |
, duration |
| T87116 |
3555-3564 |
UBERON:0003215;CL:0002063 |
denotes |
spitaliza |
| T72756 |
3565-3572 |
CL:0002063 |
denotes |
ion, an |
| T87103 |
3573-3582 |
UBERON:0000483;CL:0000066 |
denotes |
BMI), or |
| T70481 |
3583-3588 |
CL:0000066 |
denotes |
Krusk |
| T14276 |
3600-3610 |
CHEBI:35195;CHEBI:35195 |
denotes |
test (age) |
| T82555 |
3611-3623 |
CHEBI:16247;CHEBI:16247 |
denotes |
COVID-19, c |
| T309 |
3612-3620 |
SP_7 |
denotes |
COVID-19 |
| T310 |
3622-3633 |
NCBITaxon:11118 |
denotes |
coronavirus |
| T90023 |
3637-3647 |
GO:0065007 |
denotes |
ease 2019. |
| T37061 |
3648-3652 |
UBERON:0002048 |
denotes |
See |
